MultiPark: Multidisciplinary research on neurodegenerative diseases
1 – 10 of 4648
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Health surveillance for South African Para athletes: an 88-week prospective study in a resource-limited setting
- Contribution to journal › Article
-
Mark
Cerebral glucose delivery, transport and metabolism : Theory and modeling using four, three, and two tissue compartments
(2026) In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 46(2). p.534-557
- Contribution to journal › Article
-
Mark
Cognitive sequelae in post-COVID-syndrome : a Danish-Swedish case-control study
- Contribution to journal › Article
-
Mark
A High Rate of Acute Injuries in Para Alpine Skiing—A Combined Prospective Study of Injuries Reported at the Sochi 2014, PyeongChang 2018, and Beijing 2022 Paralympic Winter Games
(2026) In Scandinavian Journal of Medicine and Science in Sports
- Contribution to journal › Article
-
Mark
Epigenetic regulation of transposable elements in human brain development and disease
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Blood-Based Biomarkers of Alzheimer’s disease: Bringing plasma p-Tau to the Clinic
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Aβ antibodies target not only amyloid plaques but also distinct brain cells and vessels
- Contribution to journal › Article
-
Mark
Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study
- Contribution to journal › Article
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
- Contribution to journal › Article
-
Mark
Infusion therapies for Parkinson’s disease : where are we in 2025?
- Contribution to journal › Article
